Ingersoll Rand Inc. · NYSE:IR
Ingersoll Rand — Gardner Denver — Q2 2019 Earnings Presentation
18 slides from Ingersoll Rand's earnings presentation, Aug 1, 2019
Slide 1: Gardner Denver Q2 2019 Earnings Presentation
Gardner Denver Q2 2019 Earnings Presentation August 1, 2019
Slide 2: Replay Information
Replay Information ▪ Dial toll-free: +1.877.344.7529 ▪ International: +1.412.317.0088 ▪ Conference ID: #10133603 ▪ Log on to: https://investors.gardnerdenver.com 2
Slide 3: Disclaimer
Disclaimer Forward-Looking Statements During the course of this presentation, we may make “forward-looking statements” within the meaning of the US federal securities laws. In fact, all statements made during this presentation other than statements of historical fact are forward-looking statements.
Slide 4: Agenda
Agenda ▪ Company Highlights ▪ Gardner Denver/Ingersoll Rand Industrials Integration Update ▪ Strategy Update ▪ Segment Highlights ▪ Guidance ▪ Q&A 4
Slide 5: Q2 2019 Highlights
Q2 2019 Highlights1 Revenue of $629M, down 3% excluding FX Adjusted EPS of $0.43 and Adjusted EBITDA of $148M with margin of 23.5%2 GDP-exposed businesses (represents ~80% of revenue)3 Revenue up 4% excluding FX Triple digit Adjusted EBITDA margin expansion in Industrials and Medical segme
Slide 6: Gardner Denver/IR Industrials Transaction Update
Gardner Denver/IR Industrials Transaction Update Creating a Premier Diversified Leader in Mission-Critical Flow Creation and Industrial Products Provides Greater Scale and Reach through Leading Brands and Market Position Enhances End Market Balance and Diversity (Upstream energy reduced from ~25% to
Slide 7: Integration: 4-Step Plan Governed by GDX
Integration: 4-Step Plan Governed by GDX • 150+ employees engaged across GDI/IR Focused Team • 23 functional workstreams • Critical day 1 priorities by function and Step 1: Charter sub-function • Precise scope definition • Current state processes (value stream Step 2: Blue Print mapping) and capabil
Slide 8: Our Strategy
Our Strategy Deploy Talent Expand Margins Accelerate Growth Allocate Capital Effectively 8
Slide 9: Industrials Segment – Q2 Highlights
Industrials Segment – Q2 Highlights (Dollars in millions) As Prior YOY Ex-FX YOY Reported Year Change Change Revenue $334.3 $328.7 1.7% 5.5% Adjusted EBITDA $76.6 $71.1 7.7% 11.5% Adjusted EBITDA Margin 22.9% 21.6% 130 bps Innovation in Action Highlights: Orders flat ex-FX Revenue up 5% ex-FX
Slide 10: Energy Segment – Q2 Highlights
Energy Segment – Q2 Highlights (Dollars in millions) As Prior YOY Ex-FX YOY Reported Year Change Change Revenue $222.8 $273.1 (18.4)% (16.8)% Adjusted EBITDA $56.3 $79.7 (29.4)% (28.5)% Adjusted EBITDA Margin 25.3% 29.2% (390) bps Highlights: Innovation in Action Orders down 30% ex-FX Upstream o
Slide 11: Medical Segment – Q2 Highlights
Medical Segment – Q2 Highlights (Dollars in millions) As Prior YOY Ex-FX YOY Reported Year Change Change Revenue $72.0 $66.4 8.4% 12.0% Adjusted EBITDA $21.4 $18.0 18.9% 23.3% Adjusted EBITDA Margin 29.7% 27.1% 260 bps Acquisition of Oina Acquired July 2019 Highlights: Orders up 9% ex-FX Revenue
Slide 12: Revised 2019 Guidance
Revised 2019 Guidance 2019 Revised 2019 Guidance Guidance (April 2019) (July 2019) Revenue1 Growth (ex-FX) Growth (ex-FX) Industrials up MSD up MSD Medical up MSD up MSD Mid & Downstream Energy up MSD up MSD Upstream Energy down LDD to HSD down ~30% Total Gardner Denver up LSD to MSD down LSD FX Imp
Slide 13: Appendix
Appendix
Slide 14: Q2 2019 Financial Performance
Q2 2019 Financial Performance (Dollars in millions, excl. EPS) Revenue Adjusted EBITDA Adjusted EPS1 Down 6% Down 9% Down 1 Cent Down 3% ex-FX Margin Down 70 bps $668 $0.44 $162 $0.43 $629 $148 24.2% Margin 23.5% Margin Q2 2018 Q2 2019 Q2 2018 Q2 2019 Q2 2018 Q2 2019 Industrials +5% ex-FX Industrial
Slide 15: Q2 2019 Financial Performance
Q2 2019 Financial Performance (Dollars in millions) Working Capital Free Cash Flow 1 Leverage (Op. Working Capital as % of LTM Sales) (FCF Conversion in % and FCF in $) (Net Debt / LTM Adjusted EBITDA) Increased 40 bps Improved 0.4x Y/Y 205% 25.5% 25.1% 113% 2.4x $124M $51M 2.0x 2.0x Q2 2018 Q2 2019
Slide 16: Reconciliation of Net Income and EPS to Adjusted Net Income and Adjusted EPS
Reconciliation of Net Income and Earnings per Share to Adjusted Net Income and Adjusted Earnings per Share GARDNER DENVER HOLDINGS, INC. AND SUBSIDIARIES RECONCILIATION OF NET INCOME AND EARNINGS PER SHARE TO ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE (Dollars in millions, except per share
Slide 17: Reconciliation of Net Income to Adjusted EBITDA and CFOA to Free Cash Flow
Reconciliation of Net Income to Adjusted EBITDA and Adjusted Net Income and CFOA to Free Cash Flow GARDNER DENVER HOLDINGS, INC. AND SUBSIDIARIES RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA AND ADJUSTED NET INCOME AND CASH FLOWS - OPERATING ACTIVITIES TO FREE CASH FLOW (Dollars in millions) (Una
Slide 18: Reconciliation of Segment Adjusted EBITDA to Income Before Income Taxes
Reconciliation of Segment Adjusted EBITDA to Income Before Income Taxes GARDNER DENVER HOLDINGS, INC. AND SUBSIDIARIES RECONCILIATION OF SEGMENT ADJUSTED EBITDA TO INCOME BEFORE INCOME TAXES (Dollars in millions) (Unaudited) For the Three Month For the Six Month Period Ended Period Ended June 30, Ju